We focused on two of these pathways—Glycolysis and gluconeogenesis and Transmembrane transport of small molecules (Fig 2A)—because of their strong PTM cluster-based links to the EGF/EGFR signaling pathway and because of the importance of metabolic adaptations in the progression to advanced cancer [29]. The gene discussed is EGF; the disease is cancer.